Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis

Paul Le Turnier , Matthieu Grégoire (1) , Guillaume Deslandes , Karim Lakhal , Colin Deschanvres , Raphael Lecomte , Jean Philippe Talarmin , V. Dubée (2) , Ronan Bellouard , David Boutoille (3) , Anne-Gaëlle Leroy (3) , B.J. Gaborit (3) , Francois Raffi , Charlotte Biron , Maeva Lefebvre , Benjamin Jean Gaborit , Marie Chauveau , Nathalie Asseray , Eric Dailly , Stéphane Corvec , Pascale Bémer , Jocelyne Caillon , Aurélie Guillouzouic , Raphaël Cinotti , Emmanuel Canet , Cédric Bretonniere , Thomas Guimard , Julia Brochard , Lydie Katchatourian

1 TENS - The Enteric Nervous System in gut and brain disorders [U1235]
2 UA - Université d'Angers
3 DCNS-Nantes - DCNS Group [Nantes]

Domaines: Sciences du Vivant [q-bio]

Paul Le Turnier, Matthieu Grégoire, Guillaume Deslandes, Karim Lakhal, Colin Deschanvres, et al.. Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis. Clinical Microbiology and Infection, 2020, 26, pp.1415.e1 - 1415.e4. ⟨10.1016/j.cmi.2020.04.046⟩. ⟨hal-03491258⟩